Drug maker updates safety information on epilepsy drug

01/23/2004 | National Post (Canada)

Janssen-Ortho and Health Canada announced the release of new safety information for the drug Topamax, with the company citing five Canadian cases of metabolic acidosis in which the normal acid-base balance is disrupted. Besides symptoms of rapid breathing, persistent lack of energy and loss of appetite, those with the condition also can experience heart problems, confused thinking or reduced consciousness.

View Full Article in:

National Post (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN